AbbVie Inc.'s Q1 earnings highlight an 8.4% revenue boost, driven by Skyrizi & Rinvoq. Click for ABBV's market expansion, ...

J&J’s guselkumab gets EU approval for ulcerative colitis, offering new hope for patients who don’t respond to current ...

Google stock climbed on better-than-expected Q1 earnings and search ad revenue as management touted the new AI Overviews ...

Biosimilars are proving to be a game-changing solution in the fight against inflammatory bowel disease (IBD), offering a cost ...

The orally-active drug is currently under FDA review for psoriasis, with a decision due on 10 September, and BMS has said it remains committed to developing it for IBD. It is hoping that a phase 2 ...

GLP-1 medicines can be helpful tools for the treatment of obesity and for other important health goals, but they’re not for ...

Advice on how to manage a patient with ongoing intermittent diarrhoea after a positive FIT but negative colonoscopy ...

In IBD, microbial imbalances contribute to chronic inflammation ... guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review. Frontiers' Research Topics are ...

For people with multiple sclerosis (MS), bowel problems are a common complication of the disorder. Constipation, fecal incontinence, diarrhea, and other bowel disorders may be due to MS-related nerve ...

Oily fish (which, BTW, also includes mackerel, sardines, anchovies, and trout) contain a good deal of vitamin D, too, which ...

Explore the complexities of Ulcerative Colitis, its causes, diagnostic methods, and breakthrough treatments for better ...

A breakdown of Crohn’s disease, its symptoms, causes, and long-term impact on health. Explore the causes, symptoms, diagnosis ...